Switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, may substantially reduce serum urate levels, through URAT1 inhibition, potentially without adversely affecting ABCG2 function: findings from the SWITCH SURI studyTakeshi Osonoi, Makoto Katoh|Frontiers in Endocrinology|2025Cited by 2